{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:12:50Z","timestamp":1789236770446,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004524","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur, de la Recherche, de la Science et de la Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["equipe labellis\u00e9e"],"award-info":[{"award-number":["equipe labellis\u00e9e"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["SIRIC ILlAD"],"award-info":[{"award-number":["SIRIC ILlAD"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Understanding how malignant cells respond to chemotherapy is essential to prevent the development of resistance and to improve the efficiency of anticancer drugs. Antimitotic treatment in breast cancer cells increases NOXA, an endogenous inhibitor of the survival protein MCL-1. We herein show that whereas the extent of cell death is determined by the compensatory survival BCL-xL, NOXA\/MCL-1 balance determines the modality of cell death demise. Indeed, genetic inactivation of NOXA, which reinforces the pro-survival function of MCL-1 in cancer cells, only postpones death upon exposure to Taxol and BCL-xL antagonism with A1331852. It directs the morphology of dying cells towards a phenotype characterized by cell swelling and balloon-like bubbling, regulated by Caspase-3 and GSDME, indicating that NOXA and MCL-1 might function as negative and positive, respectively, regulators of this cell death mode. Importantly, a comparative analysis of secretomes from NOXA-proficient and NOXA-deficient cancer cells treated with Taxol revealed variations in the production of inflammatory cytokines, including IL-1\u03b1, IL-1\u03b2, and IL-18. Thus, induction of apoptosis or a vacuole-associated and inflammatory cell death, in breast cancer cells by antimitotic treatment, relies on pore-forming protein GSDME expression but also on a fine balance within the BCL2 family network.<\/jats:p>","DOI":"10.1038\/s41419-026-08965-x","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:55:09Z","timestamp":1781171709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NOXA\/MCL-1 axis determines cell-death decision between apoptosis and a GSDME-dependent cell death associated with production of inflammatory cytokines upon treatment of breast cancer cells with antimitotics"],"prefix":"10.1038","volume":"17","author":[{"given":"Alison","family":"Dumont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8764-8277","authenticated-orcid":false,"given":"Fabien","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Josso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Batard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Campone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-3888","authenticated-orcid":false,"given":"Philippe","family":"Juin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5171-9937","authenticated-orcid":false,"given":"Sophie","family":"Barill\u00e9-Nion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"8965_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23:487\u2013500.","journal-title":"Nat Immunol"},{"key":"8965_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nri.2017.9","volume":"17","author":"N Yatim","year":"2017","unstructured":"Yatim N, Cullen S, Albert ML. Dying cells actively regulate adaptive immune responses. Nat Rev Immunol. 2017;17:262\u201375.","journal-title":"Nat Rev Immunol"},{"key":"8965_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.aad0395","volume":"350","author":"N Yatim","year":"2015","unstructured":"Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reis e Sousa C, et al. RIPK1 and NF-\u03baB signaling in dying cells determines cross-priming of CD8\u207a T cells. Science. 2015;350:328\u201334.","journal-title":"Science"},{"key":"8965_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.molcel.2019.09.006","volume":"76","author":"AJ Legrand","year":"2019","unstructured":"Legrand AJ, Konstantinou M, Goode EF, Meier P. The diversification of cell death and immunity: memento mori. Mol Cell. 2019;76:232\u201342.","journal-title":"Mol Cell"},{"key":"8965_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ccell.2020.11.009","volume":"39","author":"G Petroni","year":"2021","unstructured":"Petroni G, Buqu\u00e9 A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell. 2021;39:310\u201345.","journal-title":"Cancer Cell"},{"key":"8965_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21:678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8965_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/biom10081109","volume":"10","author":"S Barill\u00e9-Nion","year":"2020","unstructured":"Barill\u00e9-Nion S, Lohard S, Juin PP. Targeting of BCL-2 family members during anticancer treatment: a necessary compromise between individual cell and ecosystemic responses? Biomolecules. 2020;10:1109.","journal-title":"Biomolecules"},{"key":"8965_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrc3538","volume":"13","author":"P Juin","year":"2013","unstructured":"Juin P, Geneste O, Gautier F, Depil S, Campone M. Decoding and unlocking the BCL-2 dependency of cancer cells. Nat Rev Cancer. 2013;13:455\u201365.","journal-title":"Nat Rev Cancer"},{"key":"8965_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41418-023-01153-w","volume":"30","author":"I Vitale","year":"2023","unstructured":"Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, et al. Apoptotic cell death in disease\u2014current understanding of the NCCD 2023. Cell Death Diff. 2023;30:1097\u2013154.","journal-title":"Cell Death Diff"},{"key":"8965_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277:61\u201375.","journal-title":"Immunol Rev"},{"key":"8965_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u201365.","journal-title":"Nature"},{"key":"8965_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"8965_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.abi5934","volume":"374","author":"K Newton","year":"2021","unstructured":"Newton K, Dixit VM, Kayagaki N. Dying cells fan the flames of inflammation. Science. 2021;374:1076\u201380.","journal-title":"Science"},{"key":"8965_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2023;23:159\u201373.","journal-title":"Nat Rev Immunol"},{"key":"8965_CR15","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.cell.2014.11.037","volume":"159","author":"A Rongvaux","year":"2014","unstructured":"Rongvaux A, Jackson R, Harman CC, Li T, West AP, de Zoete MR, et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell. 2014;159:1563\u201377.","journal-title":"Cell"},{"key":"8965_CR16","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2014.11.036","volume":"159","author":"MJ White","year":"2014","unstructured":"White MJ, McArthur K, Metcalf D, Lane RM, Cambier JC, Herold MJ, et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell. 2014;159:1549\u201362.","journal-title":"Cell"},{"key":"8965_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cell.2019.05.035","volume":"178","author":"C Zierhut","year":"2019","unstructured":"Zierhut C, Yamaguchi N, Paredes M, Luo JD, Carroll T, Funabiki H. The cytoplasmic DNA sensor cGAS promotes mitotic cell death. Cell. 2019;178:302\u2013315.e23.","journal-title":"Cell"},{"key":"8965_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13689-y","volume":"11","author":"S Lohard","year":"2020","unstructured":"Lohard S, Bourgeois N, Maillet L, Gautier F, F\u00e9tiveau A, Lasla H, et al. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment. Nat Commun. 2020;11:259.","journal-title":"Nat Commun"},{"key":"8965_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","volume":"29","author":"L Schadt","year":"2019","unstructured":"Schadt L, Sparano C, Schweiger NA, Silina K, Cecconi V, Lucchiari G, et al. Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep. 2019;29:1236\u201348.","journal-title":"Cell Rep"},{"key":"8965_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553:467\u201372.","journal-title":"Nature"},{"key":"8965_CR21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature. 2023;620:1080\u201388.","journal-title":"Nature"},{"key":"8965_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03454-9","volume":"12","author":"H An","year":"2021","unstructured":"An H, Heo JS, Kim P, Lian Z, Lee S, Park J, et al. Tetraarsenic hexoxide enhances the generation of mitochondrial ROS to promote pyroptosis by inducing the activation of caspase-3\/GSDME in triple-negative breast cancer cells. Cell Death Dis. 2021;12:159.","journal-title":"Cell Death Dis"},{"key":"8965_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.820696","volume":"12","author":"T Xu","year":"2022","unstructured":"Xu T, Wang Z, Liu J, Wang G, Zhou D, Du Y, et al. Cyclin-Dependent Kinase inhibitors function as potential immune regulators via inducing pyroptosis in triple negative breast cancer. Front Oncol. 2022;12:820696.","journal-title":"Front Oncol"},{"key":"8965_CR24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/cdd.2009.184","volume":"17","author":"T Vanden Berghe","year":"2010","unstructured":"Vanden Berghe T, Vanlangenakker N, Parthoens E, Deckers W, Devos M, Festjens N, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ. 2010;17:922\u201330.","journal-title":"Cell Death Differ"},{"key":"8965_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/ijbs.22809","volume":"14","author":"H Senju","year":"2018","unstructured":"Senju H, Kumagai A, Nakamura Y, Yamaguchi H, Nakatomi K, Fukami S, et al. Effect of IL-18 on the expansion and phenotype of human natural killer cells: application to cancer immunotherapy. Int J Biol Sci. 2018;14:331\u201340.","journal-title":"Int J Biol Sci"},{"key":"8965_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4049\/jimmunol.165.3.1307","volume":"165","author":"U Kalina","year":"2000","unstructured":"Kalina U, Kauschat D, Koyama N, Nuernberger H, Ballas K, Koschmieder S, et al. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J Immunol. 2000;165:1307\u201313.","journal-title":"J Immunol"},{"key":"8965_CR27","first-page":"127","volume":"1","author":"A Dumont","year":"2020","unstructured":"Dumont A, Lohard S, Maillet L, Juin PP, Barill\u00e9-Nion S. Noxa the BCL-2 family member behind the scenes in cancer treatment. J Cell Signal. 2020;1:127\u201343.","journal-title":"J Cell Signal"},{"key":"8965_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","volume":"288","author":"E Oda","year":"2000","unstructured":"Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000;288:1053\u20138.","journal-title":"Science"},{"key":"8965_CR29","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-05-0676","volume":"65","author":"JZ Qin","year":"2005","unstructured":"Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V, et al. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res. 2005;65:6282\u201393.","journal-title":"Cancer Res"},{"key":"8965_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12477-y","volume":"10","author":"J Montero","year":"2019","unstructured":"Montero J, Gstalder C, Kim DJ, Sadowicz D, Miles W, Manos M, et al. Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies. Nat Commun. 2019;10:5157.","journal-title":"Nat Commun"},{"key":"8965_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-13-0286","volume":"4","author":"JM Balko","year":"2014","unstructured":"Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, et al. Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov. 2014;4:232\u201345.","journal-title":"Cancer Discov"},{"key":"8965_CR32","doi-asserted-by":"crossref","unstructured":"Gavali S, Maremonti F, Tonnus W, Gembardt F, Nastassja Schlecht M, Flade K, et al. Secondary necrosis following caspase-activation can occur independently of gasdermin E. Adv Sci. 2025;e07381.","DOI":"10.1002\/advs.202507381"},{"key":"8965_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.devcel.2010.03.014","volume":"18","author":"SW Tait","year":"2010","unstructured":"Tait SW, Parsons MJ, Llambi F, Bouchier-Hayes L, Connell S, Mu\u00f1oz-Pinedo C, et al. Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev Cell. 2010;18:802\u201313.","journal-title":"Dev Cell"},{"key":"8965_CR34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","volume":"57","author":"G Ichim","year":"2015","unstructured":"Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, et al. Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol Cell. 2015;57:860\u201372.","journal-title":"Mol Cell"},{"key":"8965_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.devcel.2022.03.019","volume":"57","author":"K Cao","year":"2022","unstructured":"Cao K, Riley JS, Heilig R, Montes-G\u00f3mez AE, Vringer E, Berthenet K, et al. Mitochondrial dynamics regulate genome stability via control of caspase-dependent DNA damage. Dev Cell. 2022;57:1211\u201325.","journal-title":"Dev Cell"},{"key":"8965_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/ncb3596","volume":"19","author":"E Giampazolias","year":"2017","unstructured":"Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-\u03baB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116\u201329.","journal-title":"Nat Cell Biol"},{"key":"8965_CR37","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","volume":"185","author":"H Kalkavan","year":"2022","unstructured":"Kalkavan H, Chen MJ, Crawford JC, Quarato G, Fitzgerald P, Tait SWG, et al. Sublethal cytochrome c release generates drug-tolerant persister cells. Cell. 2022;185:3356\u201374.","journal-title":"Cell"},{"key":"8965_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245\u201354.","journal-title":"Trends Biochem Sci"},{"key":"8965_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579:415\u201320.","journal-title":"Nature"},{"key":"8965_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09397-2","volume":"10","author":"C Rogers","year":"2019","unstructured":"Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019;10:1689.","journal-title":"Nat Commun"},{"key":"8965_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04768-y","volume":"13","author":"A Haimovici","year":"2022","unstructured":"Haimovici A, H\u00f6fer C, Badr MT, Bavafaye Haghighi E, Amer T, Boerries M, et al. Spontaneous activity of the mitochondrial apoptosis pathway drives chromosomal defects, the appearance of micronuclei and cancer metastasis through the Caspase-activated DNAse. Cell Death Dis. 2022;13:315.","journal-title":"Cell Death Dis"},{"key":"8965_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108998","volume":"35","author":"B Zhou","year":"2021","unstructured":"Zhou B, Abbott DW. Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases. Cell Rep. 2021;35:108998.","journal-title":"Cell Rep"},{"key":"8965_CR43","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","volume":"42","author":"IS Afonina","year":"2015","unstructured":"Afonina IS, M\u00fcller C, Martin SJ, Beyaert R. Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity. 2015;42:991\u20131004.","journal-title":"Immunity"},{"key":"8965_CR44","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","volume":"187","author":"L Xu","year":"2024","unstructured":"Xu L, Peng F, Luo Q, Ding Y, Yuan F, Zheng L, et al. IRE1\u03b1 silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024;187:7248\u201366.","journal-title":"Cell"},{"key":"8965_CR45","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/cancers12071791","volume":"12","author":"C R\u00e9b\u00e9","year":"2020","unstructured":"R\u00e9b\u00e9 C, Ghiringhelli F. Interleukin-1\u03b2 and cancer. Cancers. 2020;12:1791.","journal-title":"Cancers"},{"key":"8965_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12705","volume":"88","author":"M Molgora","year":"2018","unstructured":"Molgora M, Supino D, Mavilio D, Santoni A, Moretta L, Mantovani A, et al. The yin-yang of the interaction between myelomonocytic cells and NK cells. Scand J Immunol. 2018;88:e12705.","journal-title":"Scand J Immunol"},{"key":"8965_CR47","doi-asserted-by":"publisher","first-page":"32722","DOI":"10.18632\/oncotarget.16281","volume":"8","author":"IH Park","year":"2017","unstructured":"Park IH, Yang HN, Lee KJ, Kim TS, Lee ES, Jung SY, et al. Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer. Oncotarget. 2017;8:32722\u201330.","journal-title":"Oncotarget"},{"key":"8965_CR48","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","volume":"116","author":"I Kaplanov","year":"2019","unstructured":"Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin GV, Shurin MR, et al. Blocking IL-1\u03b2 reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci USA. 2019;116:1361\u201369.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8965_CR49","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.ccell.2024.10.014","volume":"42","author":"K H\u00e4nggi","year":"2024","unstructured":"H\u00e4nggi K, Li J, Gangadharan A, Liu X, Celias DP, Osunmakinde O, et al. Interleukin-1\u03b1 release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity. Cancer Cell. 2024;42:2015\u201331.","journal-title":"Cancer Cell"},{"key":"8965_CR50","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","volume":"384","author":"A Bardia","year":"2021","unstructured":"Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, et al. Sacituzumab Govitecan in metastatic triple-negative breast cancer. N Engl J Med. 2021;384:1529\u201341.","journal-title":"N Engl J Med"},{"key":"8965_CR51","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s43018-022-00466-y","volume":"3","author":"A Shahbandi","year":"2022","unstructured":"Shahbandi A, Chiu FY, Ungerleider NA, Kvadas R, Mheidly Z, Sun MJS, et al. Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. Nat Cancer. 2022;3:1513\u201333.","journal-title":"Nat Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08965-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08965-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08965-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:06:45Z","timestamp":1787008005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08965-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8965"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08965-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from enrolled patients, and the protocol was approved by Minist\u00e8re de la Recherche (agreement DC-2012-1598) and local ethics committee (agreement CB 2012\/06). All methods were conducted in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"740"}}